PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1994 August; 87(8): 450–453.
PMCID: PMC1294684

Blood cholesterol and coronary heart disease: changing perspectives.

Abstract

There has been much controversy concerning the value of efforts to reduce blood cholesterol levels. In this contribution, the risks and benefits of interventions are discussed. Lowering cholesterol level by drugs is not recommended except in a small minority of subjects at very high risk of coronary heart disease (CHD), since it causes an excess of non-CHD deaths. Dietary intervention, by contrast, is safe. However, for it to be effective it must be sufficiently vigorous to achieve a drop in blood cholesterol of at least 6%, though considerably more is preferable. This action should be part of a more general effort aimed at the prevention of all Western diseases based on changes in lifestyle.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (854K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Shaper AG. Blood cholesterol: who to test. 1. Br J Hosp Med. 1992 May 6;47(9):639–641. [PubMed]
  • Betteridge DJ. Blood cholesterol: who to test. 2. Br J Hosp Med. 1992 May 6;47(9):643–644. [PubMed]
  • Hulley SB, Walsh JM, Newman TB. Health policy on blood cholesterol. Time to change directions. Circulation. 1992 Sep;86(3):1026–1029. [PubMed]
  • Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 1992 Sep;86(3):1046–1060. [PubMed]
  • Harris T, Feldman JJ, Kleinman JC, Ettinger WH, Jr, Makuc DM, Schatzkin AG. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol. 1992 Jun;45(6):595–601. [PubMed]
  • Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992 Jul 4;305(6844):15–19. [PMC free article] [PubMed]
  • Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991 Oct 19;303(6808):953–957. [PMC free article] [PubMed]
  • Ramsay LE, Yeo WW, Jackson PR. Home cholesterol testing. Lancet. 1993 Jan 30;341(8840):313–314. [PubMed]
  • Kris-Etherton PM, Krummel D, Russell ME, Dreon D, Mackey S, Borchers J, Wood PD. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc. 1988 Nov;88(11):1373–1400. [PubMed]
  • Grundy SM. Adherence to cholesterol-lowering diets. Arch Intern Med. 1992 Jun;152(6):1139–1139. [PubMed]
  • Kushner RF. Long-term compliance with a lipid-lowering diet. Nutr Rev. 1993 Jan;51(1):16–18. [PubMed]
  • Leren P. The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl. 1966;466:1–92. [PubMed]
  • Rogers MC. Sir John Scott Burdon-Sanderson (1828-1905): a pioneer in electrophysiology. Circulation. 1969 Jul;40(1):1–2. [PubMed]
  • St Clair RW. Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms. Prog Cardiovasc Dis. 1983 Sep-Oct;26(2):109–132. [PubMed]
  • Armstrong ML, Warner ED, Connor WE. Regression of coronary atheromatosis in rhesus monkeys. Circ Res. 1970 Jul;27(1):59–67. [PubMed]
  • Clarkson TB, Bond MG, Bullock BC, McLaughlin KJ, Sawyer JK. A study of atherosclerosis regression in Macaca mulatta. V. Changes in abdominal aorta and carotid and coronary arteries from animals with atherosclerosis induced for 38 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol. 1984 Aug;41(1):96–118. [PubMed]
  • Waters D, Lespérance J. Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials. Am J Med. 1991 Jul 31;91(1B):10S–17S. [PubMed]
  • Walker AR. The prevention of coronary heart disease. Am Heart J. 1966 Dec;72(6):721–724. [PubMed]
  • Schettler G. Cardiovascular diseases during and after World War II: a comparison of the Federal Republic of Germany with other European countries. Prev Med. 1979 Sep;8(5):581–590. [PubMed]
  • MALMROS H. The relation of nutrition to health; a statistical study of the effect of the war-time on arteriosclerosis, cardiosclerosis, tuberculosis and diabetes. Acta Med Scand Suppl. 1950;246:137–153. [PubMed]
  • Temple NJ. Coronary heart disease--dietary lipids or refined carbohydrates? Med Hypotheses. 1983 Apr;10(4):425–435. [PubMed]
  • Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992 Jun 20;339(8808):1523–1526. [PubMed]
  • Lyon JL, Wetzler HP, Gardner JW, Klauber MR, Williams RR. Cardiovascular mortality in Mormons and non-Mormons in Utah, 1969--1971. Am J Epidemiol. 1978 Nov;108(5):357–366. [PubMed]
  • Enstrom JE. Health practices and cancer mortality among active California Mormons. J Natl Cancer Inst. 1989 Dec 6;81(23):1807–1814. [PubMed]
  • Walker AR, Walker BF, Walker AJ, Vorster HH. Low frequency of adverse sequelae of obesity in South African rural black women. Int J Vitam Nutr Res. 1989;59(2):224–228. [PubMed]
  • Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. [PMC free article] [PubMed]
  • Walker AR, Walker BF. Plasma cholesterol, coronary heart disease and cancer. BMJ. 1989 Jul 1;299(6690):52–52. [PMC free article] [PubMed]
  • Chang-Claude J, Frentzel-Beyme R, Eilber U. Mortality pattern of German vegetarians after 11 years of follow-up. Epidemiology. 1992 Sep;3(5):395–401. [PubMed]
  • Burr ML, Sweetnam PM. Vegetarianism, dietary fiber, and mortality. Am J Clin Nutr. 1982 Nov;36(5):873–877. [PubMed]
  • Snowdon DA. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists. Am J Clin Nutr. 1988 Sep;48(3 Suppl):739–748. [PubMed]
  • Berkel J, de Waard F. Mortality pattern and life expectancy of Seventh-Day Adventists in the Netherlands. Int J Epidemiol. 1983 Dec;12(4):455–459. [PubMed]
  • Tunstall-Pedoe H, Smith WC. Cholesterol as a risk factor for coronary heart disease. Br Med Bull. 1990 Oct;46(4):1075–1087. [PubMed]
  • Posner BM, Cupples LA, Gagnon D, Wilson PW, Chetwynd K, Felix D. Healthy People 2000. The rationale and potential efficacy of preventive nutrition in heart disease: the Framingham Offspring-Spouse Study. Arch Intern Med. 1993 Jul 12;153(13):1549–1556. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press